Prinaberel
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
| |
CAS Number | 524684-52-4 |
PubChem (CID) | 5326893 |
ChemSpider | 4484184 |
ECHA InfoCard | 100.222.969 |
Chemical and physical data | |
Formula | C15H10FNO3 |
Molar mass | 271.243 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Prinaberel (INN, USAN) (developmental code names ERB-041, WAY-202041) is a synthetic, non-steroidal, and highly selective agonist of the ERβ subtype of the estrogen receptor.[1] It is used in scientific research to elucidate the role of the ERβ receptor.[2] Studies have indicated that selective ERβ agonists like prinaberel could be useful in the clinical treatment of a variety of medical conditions including inflammatory bowel disease, rheumatoid arthritis, endometriosis, and sepsis.[3] Accordingly, prinaberel either was or still is under investigation by Wyeth for the treatment of some of these conditions.[4]
As of 2015, prinaberel is the only synthetic, selective ERβ agonist to have reached human clinical trials.[5]
See also
- WAY-200070
- Menerba
- Liquiritigenin
- Diarylpropionitrile (DPN)
- PHTPP
- Propylpyrazoletriol (PPT)
- Methylpiperidinopyrazole (MPP)
- (R,R)-Tetrahydrochrysene ((R,R)-THC)
References
- ↑ Harris HA, Albert LM, Leathurby Y, et al. (October 2003). "Evaluation of an estrogen receptor-beta agonist in animal models of human disease". Endocrinology. 144 (10): 4241–9. doi:10.1210/en.2003-0550. PMID 14500559.
- ↑ Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA (May 2005). "Reflections on the discovery and significance of estrogen receptor beta". Endocrine Reviews. 26 (3): 465–78. doi:10.1210/er.2004-0027. PMID 15857973.
- ↑ Harris HA (2006). "Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential". Ernst Schering Foundation Symposium Proceedings (1): 149–61. PMID 17824176.
- ↑ "Prinaberel - Wyeth phase change II, USA (endometriosis)". R & D Focus Drug News. 2006-06-05. Retrieved 2012-05-20.
- ↑ Narayanan, Ramesh; Dalton, James T. (2015). "Selective Estrogen Receptor Modulators (SERMs) and Selective Androgen Receptor Modulators (SARMs)": 205–227. doi:10.1007/978-3-319-18729-7_11.
External links
This article is issued from Wikipedia - version of the 9/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.